XML 36 R23.htm IDEA: XBRL DOCUMENT v3.20.2
INCOME TAXES
9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
On March 27, 2020, the United States enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) in response to the COVID-19 pandemic. Certain provisions of the legislation had a significant impact on the expected annual effective tax rate, income tax payable, and deferred income tax positions of the Company for the three- and nine- month periods ended September 30, 2020. The Company continues to evaluate the provisions of the CARES Act.
For the three months ended September 30, 2020, the Company recognized an income tax benefit of $1.3 million compared to income tax expense of $7.4 million for the same period in the prior year. The effective tax rate for this period was 49.4% compared to 22.6% for the same period in the prior year. The Company recognized an income tax benefit of $10.3 million in the first nine months of 2020 compared to expense of $21.2 million for the same period in the prior year. The effective tax rates for the first nine months of 2020 and 2019 were 9.1% and 23.0%, respectively. For the first nine months of 2020, these effective tax rates differ from the US Federal statutory rate of 21% primarily due to the impact of state and local taxes, impairment of non-deductible goodwill, provisions related to the CARES Act, and discrete items incurred related to stock-based compensation. For the first nine months of 2019, these effective tax rates differ from the US Federal statutory rate of 21% primarily due to the impact of state and local taxes and discrete items related to research and development credits and stock-based compensation.